Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
Rituximab (RTX), an anti-CD20 monoclonal antibody, has shown to be an effective induction treatment for small-vessel vasculitides associated with antineutrophil cytoplasm antibodies (AAV) in both newly diagnosed and relapsing patients. However, the role of RTX in the management of the most severe ca...
Main Authors: | Dario Roccatello, Savino Sciascia, Stefano Murgia, Giacomo Quattrocchio, Michela Ferro, Emanuele De Simone, Carla Naretto, Antonella Barreca, Andrea Sammartino, Daniela Rossi, Roberta Fenoglio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.777134/full |
Similar Items
-
Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California
by: Deepika Singh, et al.
Published: (2023-07-01) -
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience
by: Dario Roccatello, et al.
Published: (2020-10-01) -
Renal involvement as a unique manifestation of hemophagocytic syndrome
by: Dario Roccatello, et al.
Published: (2022-10-01) -
Granulomatosis with polyangiitis: An atypical initial presentation
by: Catarina Vilaça Pereira, et al.
Published: (2022-01-01) -
Migrant cavitation as primary involvement in a particular case of granulomatosis with polyangiitis
by: Francesco Manti, MD, et al.
Published: (2022-10-01)